相似文献
1
The Yin and Yang of bone morphogenetic proteins in cancer.
Cytokine Growth Factor Rev. 2010 Aug;21(4):299-313. doi: 10.1016/j.cytogfr.2010.06.003. Epub 2010 Aug 4.
2
[BMPs and cancer].
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2013 Sep;38(9):959-65. doi: 10.3969/j.issn.1672-7347.2013.09.016.
3
Bone morphogenetic proteins.
Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890.
4
Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
Biochem Soc Trans. 2016 Aug 15;44(4):1117-34. doi: 10.1042/BST20160069.
5
Bone morphogenetic proteins in development and progression of breast cancer and therapeutic potential (review).
Int J Mol Med. 2009 Nov;24(5):591-7. doi: 10.3892/ijmm_00000269.
6
Bone morphogenetic proteins and their receptor signaling in prostate cancer.
Histol Histopathol. 2007 Oct;22(10):1129-47. doi: 10.14670/HH-22.1129.
7
Bone morphogenetic proteins and growth differentiation factors as drug targets in cardiovascular and metabolic disease.
Drug Discov Today. 2006 May;11(9-10):405-11. doi: 10.1016/j.drudis.2006.03.016.
8
Bone Morphogenetic Proteins: Promising Molecules for Bone Healing, Bioengineering, and Regenerative Medicine.
Vitam Horm. 2015;99:293-322. doi: 10.1016/bs.vh.2015.06.002. Epub 2015 Jul 15.
9
Signal transduction and biological functions of bone morphogenetic proteins.
Front Biosci. 2004 Jan 1;9:349-58. doi: 10.2741/1090.
10
Bone morphogenetic proteins: an unconventional approach to isolation of first mammalian morphogens.
Cytokine Growth Factor Rev. 1997 Mar;8(1):11-20. doi: 10.1016/s1359-6101(96)00049-4.
引用本文的文献
1
The BMP Signaling Pathway: Bridging Maternal-Fetal Crosstalk in Early Pregnancy.
Reprod Sci. 2025 May;32(5):1427-1445. doi: 10.1007/s43032-024-01777-4. Epub 2025 Jan 16.
2
A new method for network bioinformatics identifies novel drug targets for mucinous ovarian carcinoma.
NAR Genom Bioinform. 2024 Aug 24;6(3):lqae096. doi: 10.1093/nargab/lqae096. eCollection 2024 Sep.
3
Shaping Oncogenic Microenvironments: Contribution of Fibronectin.
Front Cell Dev Biol. 2024 Apr 10;12:1363004. doi: 10.3389/fcell.2024.1363004. eCollection 2024.
4
Novel urine cell-free DNA methylation markers for hepatocellular carcinoma.
Sci Rep. 2023 Dec 7;13(1):21585. doi: 10.1038/s41598-023-48500-y.
5
Upregulation of BMP1 through ncRNAs correlates with adverse outcomes and immune infiltration in clear cell renal cell carcinoma.
Eur J Med Res. 2023 Oct 17;28(1):440. doi: 10.1186/s40001-023-01422-x.
6
An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer.
Dis Markers. 2022 Oct 11;2022:7899961. doi: 10.1155/2022/7899961. eCollection 2022.
7
The Yin-Yang Dynamics in Cancer Pharmacogenomics and Personalized Medicine.
Methods Mol Biol. 2022;2547:141-163. doi: 10.1007/978-1-0716-2573-6_6.
8
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer.
Cell Rep. 2022 Jul 26;40(4):111066. doi: 10.1016/j.celrep.2022.111066.
9
Engineering of a Microscale Niche for Pancreatic Tumor Cells Using Bioactive Film Coatings Combined with 3D-Architectured Scaffolds.
ACS Appl Mater Interfaces. 2022 Mar 23;14(11):13107-13121. doi: 10.1021/acsami.2c01747. Epub 2022 Mar 11.
10
The Use of Bone Grafts, Bone Graft Substitutes, and Orthobiologics for Osseous Healing in Foot and Ankle Surgery.
Foot Ankle Orthop. 2019 Jul 10;4(3):2473011419849019. doi: 10.1177/2473011419849019. eCollection 2019 Jul.
本文引用的文献
1
Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein 4.
Breast Cancer Res Treat. 2010 Nov;124(2):377-86. doi: 10.1007/s10549-010-0808-0. Epub 2010 Feb 25.
2
Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.
Neoplasia. 2010 Feb;12(2):192-205. doi: 10.1593/neo.91836.
3
In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors.
ACS Chem Biol. 2010 Feb 19;5(2):245-53. doi: 10.1021/cb9002865.
4
Autocrine bone morphogenetic protein-9 signals through activin receptor-like kinase-2/Smad1/Smad4 to promote ovarian cancer cell proliferation.
Cancer Res. 2009 Dec 15;69(24):9254-62. doi: 10.1158/0008-5472.CAN-09-2912.
5
Applications of small molecule BMP inhibitors in physiology and disease.
Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):409-18. doi: 10.1016/j.cytogfr.2009.10.021. Epub 2009 Nov 14.
6
Control of BMP gene expression by long-range regulatory elements.
Cytokine Growth Factor Rev. 2009 Oct-Dec;20(5-6):509-15. doi: 10.1016/j.cytogfr.2009.10.011. Epub 2009 Nov 8.
7
BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
Exp Cell Res. 2010 Jan 1;316(1):24-37. doi: 10.1016/j.yexcr.2009.10.010. Epub 2009 Oct 14.
8
Viral vector-induced expression of bone morphogenetic protein 2 produces inhibition of tumor growth and bone differentiation of stem cells.
Cancer Gene Ther. 2010 Feb;17(2):80-5. doi: 10.1038/cgt.2009.56. Epub 2009 Oct 16.
9
Independent and cooperative roles of tumor necrosis factor-alpha, nuclear factor-kappaB, and bone morphogenetic protein-2 in regulation of metastasis and osteomimicry of prostate cancer cells and differentiation and mineralization of MC3T3-E1 osteoblast-like cells.
Cancer Sci. 2010 Jan;101(1):103-11. doi: 10.1111/j.1349-7006.2009.01356.x. Epub 2009 Sep 9.
10
Expression pattern and clinical prognostic relevance of bone morphogenetic protein-2 in human gliomas.
Jpn J Clin Oncol. 2009 Oct;39(10):625-31. doi: 10.1093/jjco/hyp094.
Zotero 插件